Current trends in the treatment of ARVI: how to avoid polypharmacy?

Abstract

Acute respiratory infections (ARI) are leading among children's infectious diseases; they may be caused by different viruses belonging to at least 6 families (Orthomyxo-, Paramyxo-, Picorna-, Adeno-, Corona-, Herpes-viridae), while the flu virus is not the dominating one, causing disease only during the epidemic outbreak of influenza. [1] The bacterial flora (S.Pneumonia, H. influenzae, Mycoplasma pneumonia, Klebsiella pneumoniae, etc.) participates in the process as well, both alone and in combination with viruses.

Keywords

• острые респираторные инфекции
• дети
• терапия
• полипрагмазия
• инозин пранобекс
• acute respiratory infections
• children
• therapy
• polypharmacy
• inosine pranobex